chr2-126693929-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002101.5(GYPC):c.172G>A(p.Asp58Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,610,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002101.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GYPC | NM_002101.5 | c.172G>A | p.Asp58Asn | missense_variant | 3/4 | ENST00000259254.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GYPC | ENST00000259254.9 | c.172G>A | p.Asp58Asn | missense_variant | 3/4 | 1 | NM_002101.5 | P2 | |
GYPC | ENST00000409836.3 | c.115G>A | p.Asp39Asn | missense_variant | 2/3 | 1 | A2 | ||
GYPC | ENST00000356887.12 | c.109G>A | p.Asp37Asn | missense_variant | 4/5 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251324Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135804
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1458402Hom.: 0 Cov.: 29 AF XY: 0.00000551 AC XY: 4AN XY: 725766
GnomAD4 genome AF: 0.000145 AC: 22AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.172G>A (p.D58N) alteration is located in exon 3 (coding exon 3) of the GYPC gene. This alteration results from a G to A substitution at nucleotide position 172, causing the aspartic acid (D) at amino acid position 58 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at